Research Article: Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice
Introduction:
A fixed combination of bictegravir/emtricitabine/tenofovir alafenamide (BFTAF, Biktarvy ® ), an HIV integrase strand transfer inhibitor (InSTI) associated with two nucleoside reverse transcriptase inhibitors, has been available in Italy since June for the treatment of people living with HIV infection (PLWH).
Read more